SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003848
Filing Date
2019-05-02
Accepted
2019-05-02 16:06:36
Documents
107
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20190331x10q.htm 10-Q 2350856
2 EX-31.1 irwd-20190331ex3113a7e4d.htm EX-31.1 18543
3 EX-31.2 irwd-20190331ex3124a2cfd.htm EX-31.2 18512
4 EX-32.1 irwd-20190331ex321533b09.htm EX-32.1 8474
5 EX-32.2 irwd-20190331ex322987e58.htm EX-32.2 8616
  Complete submission text file 0001558370-19-003848.txt   9980465

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20190331.xml EX-101.INS 2048204
7 EX-101.SCH irwd-20190331.xsd EX-101.SCH 83098
8 EX-101.CAL irwd-20190331_cal.xml EX-101.CAL 78027
9 EX-101.DEF irwd-20190331_def.xml EX-101.DEF 415868
10 EX-101.LAB irwd-20190331_lab.xml EX-101.LAB 667312
11 EX-101.PRE irwd-20190331_pre.xml EX-101.PRE 673737
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 19791904
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences